P-glycoprotein expression and chemosensitivity in highly purified fresh human gastrointestinal cancer cells

Hepato-Gastroenterology

Volumn 46, Issue 25, 1999, Pages 316-321

  Hotta, Tsukasa ^a   Tanimura, Hiroshi ^a   Tsunoda, Takuya ^a   Iwahashi, Makoto ^a   Tani, Masaji ^a   Noguchi, Kohei ^a   Mizobata, Shizuma ^a   Arii, Kazuo ^a   Terasawa, Hiroshi ^a   Nakamori, Mikihito ^a   Yamaue, Hiroki ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Chemosensitivity test; Colorectal cancer; Fresh human tumor cells; Gastric cancer; Multidrug resistance; P glycoprotein

Indexed keywords

DOXORUBICIN; GLYCOPROTEIN P;

ARTICLE; CANCER CELL; CHEMOSENSITIVITY; CLINICAL ARTICLE; COLORECTAL CANCER; DRUG SENSITIVITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; STOMACH CANCER;

ANTIBIOTICS, ANTINEOPLASTIC; COLORECTAL NEOPLASMS; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; HUMANS; P-GLYCOPROTEIN; STOMACH NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0033042839     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. 1 Higgins GA, Humphrey E, Juler GL, LeVeen HH, McCaughan J, Keehn RJ: Adjuvant chemotherapy in the surgical treatment of large bowel cancer. Cancer 1976; 38:1461-1467.
2. 2 Gastrointestinal Tumor Study Group: Adjuvant therapy of colon cancer: results of a prospectively randomized trial. N Engl J Med 1984; 310:737-743.
3. 3 Gastrointestinal Tumor Study Group: Prolongation of the disease-Free interval in surgically treated rectal carcinoma. N Engl J Med 1985; 312:1465-1472.
4. 4 Agrez MV, Lieber MM: In vitro chemotherapy sensitivity testing of primary human colorectal carcinomas. J Surg Oncol 1983; 22:269-272.
5. 5 Maehara Y, Anai H, Kusumoto H, Kusumoto K, Sugimachi K: Colorectal carcinoma in vitro is more sensitive to 1-hexyl-carbamoyl-5-fluorouracil compared with six other antitumor drugs: Carboquone, Adriamycin®, Mitomycin C, Aclacinomycin A, Cisplatin, 5-fluorouracil. Dis Colon Rectum 1988; 31:62-67.
6. 6 Ueo H, Maehara Y, Saito A, Sakaguchi Y, Kohnoe S, Sugimachi K: Human colon cancer tissues are more sensitive than rectal cancer tissues to antitumor drugs in vitro. Oncology 1991; 48:158-161.
7. 7 Carmichael J, Mitchell JB, Degraff WG, Gamson J, Gazdar AF, Johnson BE, Glatstein E, Minna JD: Chemosensitivity testing of human lung cancer cell lines using the MTT assay. Br J Cancer 1985; 57:540-547.
8. 8 Mosmann T: Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods 1983; 65:55-63.
9. 9 Twentyman PR, Fox NE, Rees JKH: Chemosensitivity testing of fresh leukaemia cells using the MTT colorimetric assay. Br J Haematol 1989; 71:19-24.
10. 10 Campling BJ, Pym J, Baker HM, Cole SPC, Lam YM: Chemosensitivity testing of small cell lung cancer using the MTT assay. Br J Cancer 1991; 63:75-83.
11. 11 Yamaue H, Tanimura H, Tsunoda T, Tani M, Iwahashi M, Noguchi K, Tamai M, Hotta T, Arii K: Chemosensitivity testing with highly purified fresh human tumour cells with the MTT colorimetric assay. Eur J Cancer 1991; 27:1258-1263.
12. 12 Yamaue H, Tanimura H, Noguchi K, Hotta T, Tani M, Tsunoda T, Iwahashi M, Tamai M, Iwakura S: Chemosensitivity testing of fresh human gastric cancer with highly purified tumour cells using the MTT assay. Br J Cancer 1992; 66:794-799.
13. 13 Yamaue H, Tanimura H, Nakamori M, Noguchi K, Iwahashi M, Tani M, Hotta T, Murakami K, Ishimoto K: Clinical evaluation of chemosensitivity testing for patients with colorectal cancer using MTT assay. Dis Colon Rectum 1996; 39:416-422.
14. 14 Gottesman MM, Pastan I: Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem 1993; 62:385-427.
15. 15 Riordan JR, Deuchars K, Kartner N, Alon N, Trent J, Ling V: Amplification of P-glycoprotein genes in multidrug-resistant mammalian cell lines. Nature 1985; 316:817-819.
16. 16 Roninson IB, Chin JE, Choi K, Gros P, Housman DE, Fojo A, Shen D-W, Gottesman MM, Pastan I: Isolation of human mdr DNA sequences amplified in multidrug-resistant KB carcinoma cells. Proc Natl Acad Sci USA 1986; 83:4538-4542.
17. 17 Fojo AT, Ueda K, Slamon DJ, Poplack DG, Gottesman MM, Pastan I: Expression of a multidrug-resistance gene in human tumors and tissues. Proc Natl Acad Sci USA 1987; 84:265-269.
18. 18 Goldstein LJ, Galski H, Fojo A, Willingham M, Lai SL, Gazdar A, Pirker R, Green A, Crist W, Brodeur GM, Lieber M, Cossman J, Gottesman MM, Pastan I: Expression of a multidrug resistance gene in human cancers. J Natl Cancer Inst 1989; 81:116-124.
19. 19 Ferguson PJ, Cheng Y: Phenotypic instability of drug sensitivity in a human colon carcinoma cell line. Cancer Res 1989; 49:1148-1153.
20. 20 Clifford SC, Thomas DJ, Neal DE, Lunec J: Increased mdr1 gene transcript levels in high-grade carcinoma of the bladder determined by quantitative PCR-based assay. Br J Cancer 1994; 69:680-686.
21. 21 Volm M, Mattern J, Samsel B: Overexpression of P-glycoprotcin and glutathione S-transferase-p in resistant non-small cell lung carcinomas of smokers. Br J Cancer 1991; 64:700-704.
22. 22 Kartner N, Evernden-Porelle D, Bradley G, Ling V: Detection of P-glycoprotein in multidrug-resistant cell lines by monoclonal antibodies. Nature 1985; 316:820-823.
23. 23 Leonce S, Pierre A, Anstett M, Perez V, Genton A, Bizzari JP, Atassi G: Effects of a new triazinoaminopiperidine derivative on adriamycin accumulation and retention in cells displaying p-glycoprotein-mediated multidrug resistance. Biochem Pharmacol 1992; 44:1707-1715.
24. 24 Thierry AR, Jorgensen TJ, Forst D, Belli JA, Dritschilo A, Rahman A: Multidrug resistance in Chinese hamster cells: Effect of liposome-encapsulated doxorubicin. Cancer Commun 1989; 1:311-316.
25. 25 Tamai M, Tanimura H, Yamaue H, Iwahashi M, Tsunoda T, Tani M, Noguchi K, Mizobata S, Hotta T, Arii K, Terasawa H: Clinical significance of quantitative analysis of carcinoembryonic antigen assessed by flow cytometry in fresh human gastric cancer cells. Cancer Letters 1995; 90:111-117.
26. 26 Yamauchi M, Kumazawa H, Satta T, Sugawara I, Isobe K, Kodera Y, Ito K, Watanabe T, Takagi H: Prediction of doxorubicin resistance in gastrointestinal canter by P-glycoprotein staining. Eur J Cancer 1992; 28A: 1422-1427.
27. 27 DeSimone PA, Davila E, Jochimsen PR, Bartolucci AA: High-dose cisplatin in the treatment of advanced adenocarcinoma of the colon and rectum: a southeastern cancer study group trial. Cancer Treat Rep 1986; 70:1229-1230.
28. 28 Loehrer PJ, Einhorn LH, Williams SD, Hui SL, Estes NC, Pennington K: Cisplatin plus 5-FU for the treatment of adenocarcinoma of the colon. Cancer Treat Rep 1985; 69:1359-1363.
29. 29 Tsuruo T, Iida H, Tsukagoshi S, Sakurai Y: Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil. Cancer Res 1981; 41:1967-1972.
30. 30 Slater LM, Sweet P, Stupecky M, Gupta S: Cyclosporin A reverses vincristine and daunorubicin resistance in acute lymphatic leukemia in vitro. J Clin Invest 1986; 77:1405-1408.
31. 31 Hotta T, Tanimura H, Yamaue H, Iwahashi M, Tani M, Tsunoda T, Tamai M, Noguchi K, Mizobata S, Arii K, Terasawa H: Tamoxifen circumvents the multidrug resistance in fresh human gastrointestinal cancer cells. J Surg Res 1996; 66:31-35.
32. 32 Hotta T, Tanimura H, Yamaue H, Iwahashi M, Tani M, Tsunoda T, Tamai M, Noguchi K, Mizobata S, Arii K, Terasawa H: Modulation of multidrug resistance by cepharanthine in fresh human gastrointestinal tumor cells. Oncology 1997; 54:153-157.